Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    Home»Hong Kong»China All Access Clarifies Allegations Made in Triam Report, Applies for Resumption of Trading
    China All Access
    China All Access has published a clarification announcement in response to a number of allegations made in a report issued by Triam Research.
    Hong Kong

    China All Access Clarifies Allegations Made in Triam Report, Applies for Resumption of Trading

    Marie JonesBy Marie JonesDecember 19, 2016Updated:December 22, 2016No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    HONG KONG — China All Access (Holdings) Limited (“China All Access” or “the Company”; stock code: 633.HK) today has published a clarification announcement in response to a number of allegations made in a report (the “Allegation Report”) issued by Triam Research (“Triam”).

    For example, the discrepancy in revenue from the Communication Application Segment that was reported in the 2015 Financial Statements and SAIC filing is due to 1) the difference in the practice used for the SAIC filing of the Company’s PRC subsidiaries and the accounting treatments adopted in the 2015 Financial Statements, and 2) some of the Company’s revenue in 2015 being derived from sales in Hong Kong.

    Therefore the SAIC filing alone cannot fully demonstrate the Company’s entire revenue contributed by the Communication Application Segment. Please refer to the announcement for clarifications about other allegations.

    The Company’s Position

    1. The Company has not been contacted or interviewed by Triam before the issuance of the Allegation Report to verify any data or information stated in the Allegation Report. Therefore, the content of the Allegation Report is unconfirmed.

    2. Triam is an unknown organization and has never revealed its true identity and its registered business address nor the identity and qualification of the author of the Allegation Report. Its credibility is extremely questionable. The Board believes that the Allegation Report was published as a means for Triam to possibly derive benefit as a short seller of securities and may have short sold the Company’s shares.

    3. The Board vigorously denies the allegations made against the Company in the Allegation Report, and considers the information contained in the Allegation Report to be incomplete, biasedly selected and presented and materially misleading.

    4. The Company will consider and adopt all reasonable measures to protect the interest of the shareholders of the Company and reserves the right to take legal actions against Triam.

    Resumption of Trading

    An application has been made by the Company to resume trading of the Company’s shares on the Stock Exchange with effect from 9:00 a.m. on Monday, 19 December 2016.

    (The views expressed here are that of China All Access and not of Business News Asia)

    China All Access Hong Kong Triam Research
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleLegend Strategy Appoints Mr. Lu Zefeng as Non-executive Director
    Next Article qbeats Welcomes Morningstar, Inc. into the Fold

    Related Posts

    HKTDC’s New Executive Director Sophia Chong takes up post

    October 2, 2025

    HKTDC Hong Kong International Diamond, Gem & Pearl Show opens today, International Jewellery Show begins Tuesday

    March 2, 2025

    Hong Kong rated as leading sustainable business hub

    February 24, 2025
    Add A Comment

    Comments are closed.

    Latest News

    • ASN 2026: HighTide Therapeutics Presents New HTD1801 Data Highlighting Therapeutic Potential in Chronic Kidney Disease
    • MicroVision Begins Commercial Production of MOVIA(TM) Pro for Superior Short-Range Sensing and Onboard Perception, Enabling Physical AI at the Edge
    • New Global Initiative Seeks to Modernize Health Workforce Mobility
    • P&G, Nestle, Mars, AstraZeneca, ITC and Bekaert win OMP Supply Chain Awards
    • Zhipu, Jiangmen, QuantGroup and Other Investors Join Forces to Back RMB 1 Billion Cognitive Intelligence Venture Capital Fund for Physical AI Ecosystem Development
    • Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
    • Chervon Appoints Stephen Sarnocinski to President – End User Research, Sales and Service – OPE Commercial Landscaping Market Global
    • PFN and Tenstorrent Selected for NEDO Project on “xPU Design and Development Incorporating Photonics Electronics Integration Technology”
    • Hong Kong International Optical Fair opens in November
    • OrbusNeich Expands European Footprint via Acquisition of Italian Distributor
    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.